Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in breast cancer that can be reversed by PI3K/mTOR inhibitors
Zijie Cai, Jingru Wang, Yudong Li, et al.
Science China Life Sciences (2022) Vol. 66, Iss. 1, pp. 94-109
Closed Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K/Akt/mTOR pathway
Kumar Ganesan, Cong Xu, Jianming Wu, et al.
Science China Life Sciences (2024) Vol. 67, Iss. 9, pp. 1849-1866
Closed Access | Times Cited: 44
Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells
Pankaj Garg, Jyoti Malhotra, Prakash Kulkarni, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2478-2478
Open Access | Times Cited: 34
HMGA1 augments palbociclib efficacy via PI3K/mTOR signaling in intrahepatic cholangiocarcinoma
Zhipeng Li, Huaxin Zhou, Zhijia Xia, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 40
The pathophysiology of the cell cycle in cancer and treatment strategies using various cell cycle checkpoint inhibitors
Sami G. Almalki
Pathology - Research and Practice (2023) Vol. 251, pp. 154854-154854
Closed Access | Times Cited: 29
Polyphenol-Loaded Nano-carriers for Breast Cancer Therapy: A Comprehensive Review
Asif Ahmad Bhat, Gaurav Gupta, Muhammad Afzal, et al.
BioNanoScience (2024) Vol. 14, Iss. 4, pp. 4219-4237
Closed Access | Times Cited: 11
TP53 to mediate immune escape in tumor microenvironment: an overview of the research progress
Kaili Zhu, Fei Su, Jingru Yang, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Open Access | Times Cited: 10
Gallic acid ameliorates endometrial hyperplasia through the inhibition of the PI3K/AKT pathway and the down-regulation of cyclin D1 expression
Caijie Zheng, Yi Wang, Beilei Bi, et al.
Journal of Pharmacological Sciences (2024) Vol. 155, Iss. 1, pp. 1-13
Open Access | Times Cited: 7
The molecular subtyping and precision medicine in triple-negative breast cancer---based on Fudan TNBC classification
Lijuan Weng, Jian‐Liang Zhou, Shenchao Guo, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
LncRNA EILA promotes CDK4/6 inhibitor resistance in breast cancer by stabilizing cyclin E1 protein
Zijie Cai, Qianfeng Shi, Yudong Li, et al.
Science Advances (2023) Vol. 9, Iss. 40
Open Access | Times Cited: 16
Nanoparticle (NP)-mediated APOC1 silencing to inhibit MAPK/ERK and NF-κB pathway and suppress breast cancer growth and metastasis
Shaomin Liu, Fengqian Zhang, Yixia Liang, et al.
Science China Life Sciences (2023) Vol. 66, Iss. 11, pp. 2451-2465
Closed Access | Times Cited: 14
Therapeutic SHPRH-146aa encoded by circ-SHPRH dynamically upregulates P21 to inhibit CDKs in neuroblastoma
Saishuo Chang, Dong Ren, Li Zhang, et al.
Cancer Letters (2024) Vol. 598, pp. 217120-217120
Closed Access | Times Cited: 5
CDK4/6 Inhibitor Resistance in Hormone Receptor-Positive Metastatic Breast Cancer: Translational Research, Clinical Trials, and Future Directions
Jin Sun Lee, Hannah Hackbart, Xiaojiang Cui, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11791-11791
Open Access | Times Cited: 11
α-synuclein regulates Cyclin D1 to promote abnormal initiation of the cell cycle and induce apoptosis in dopamine neurons
Xiaokang Jia, Qiliang Chen, Ciyu Yao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116444-116444
Open Access | Times Cited: 4
Targeting STAT3 potentiates CDK4/6 inhibitors therapy in head and neck squamous cell carcinoma
Lin Dong, Chao Liu, Haoyang Sun, et al.
Cancer Letters (2024) Vol. 593, pp. 216956-216956
Closed Access | Times Cited: 4
CXCR4 promotes tumor stemness maintenance and CDK4/6 inhibitors resistance in ER-positive breast cancer
Qiuling Shi, Yang Wang, Yiye Ouyang, et al.
Breast Cancer Research (2025) Vol. 27, Iss. 1
Open Access
TMEM45A enhances palbociclib resistance and cellular glycolysis by activating AKT/mTOR signaling pathway in HR+ breast cancer
Cui Chen, Zehong Chen, Jie Zhao, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Cancer stem-like cells stay in a plastic state ready for tumor evolution
Jiali Xu, Hou‐De Zhang, Zhihao Nie, et al.
Neoplasia (2025) Vol. 61, pp. 101134-101134
Open Access
A circRNA–mRNA pairing mechanism regulates tumor growth and endocrine therapy resistance in ER-positive breast cancer
Yi Jia, Jiao Du, Xue Chen, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 8
Open Access
Astragalin inhibits the proliferation of high-risk HPV-positive cervical epithelial cells and attenuates malignant cervical lesions
Wei Zeng, Qiang Chen
Cytotechnology (2025) Vol. 77, Iss. 3
Closed Access
GINS1 facilitates the development of lung adenocarcinoma via Wnt/β-catenin activation
Luyuan Ma, Rongyang Li, Pengyong Li, et al.
World Journal of Surgical Oncology (2025) Vol. 23, Iss. 1
Open Access
Expert Consensus on the Clinical Application of PI3K/AKT/mTOR Inhibitors in the Treatment of Breast Cancer (2025 Edition)

Cancer Innovation (2025) Vol. 4, Iss. 3
Open Access
Potential therapeutic targets of eukaryotic translation initiation factors in tumor therapy
Yujie Zhang, Tianyou Liu, Pengyu Li, et al.
European Journal of Medicinal Chemistry (2025), pp. 117638-117638
Closed Access
The Therapeutic Efficacy and Mechanism of Action of Gnetin C, a Natural Compound from the Melinjo Plant, in a Preclinical Mouse Model of Advanced Prostate Cancer
Gisella Campanelli, Ekniel Francois, Prashanth Parupathi, et al.
Cancers (2024) Vol. 16, Iss. 7, pp. 1344-1344
Open Access | Times Cited: 3
TBL2 Promotes Tumorigenesis via PRMT5/WDR77‐Mediated AKT Activation in Breast Cancer
Xiuqing Lu, Chao Zhang, Lewei Zhu, et al.
Advanced Science (2024)
Open Access | Times Cited: 3
The Evolving Pathways of the Efficacy of and Resistance to CDK4/6 Inhibitors in Breast Cancer
Inês Gomes, Catarina Abreu, Luís Costa, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4835-4835
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top